Back | Next |
home / stock / nrbo / nrbo message board
Subject | By | Source | When |
---|---|---|---|
$NRBO what do you make of this data? | SmellMyFinger | investorshub | 01/23/2024 8:40:01 AM |
got some short data | reena969 | investorshub | 01/23/2024 4:14:57 AM |
MomentumIts trading | PENNY DIPZ | investorshub | 01/22/2024 4:46:13 PM |
Time for a bounce? | SmellMyFinger | investorshub | 01/22/2024 12:49:50 PM |
$NRBO The trading last trade up | tw0122 | investorshub | 01/22/2024 12:11:16 PM |
The trading | Arnold25764 | investorshub | 01/22/2024 2:14:17 AM |
just the news we needed | PENNY DIPZ | investorshub | 01/22/2024 12:50:53 AM |
$NRBO The trading | SmellMyFinger | investorshub | 01/21/2024 1:33:43 PM |
$NRBO what do you make of this data? | PennyPusher786 | investorshub | 01/21/2024 11:00:43 AM |
$NRBO short squeeze all day | BesaoT35 | investorshub | 01/20/2024 11:33:35 PM |
MomentumIts now last up | subslover | investorshub | 01/20/2024 8:36:58 PM |
Found an interesting article | glens0 | investorshub | 01/20/2024 7:14:30 PM |
bears are running | SmellMyFinger | investorshub | 01/20/2024 5:57:58 PM |
MomentumIts now last trade up | SmellMyFinger | investorshub | 01/20/2024 5:01:56 PM |
$NRBO Good read | 81vette | investorshub | 01/20/2024 3:49:02 PM |
When is this gonna take off? | tw0122 | investorshub | 01/20/2024 2:27:16 PM |
$NRBO The trading | tw0122 | investorshub | 01/20/2024 1:11:03 PM |
Price now | 81vette | investorshub | 01/20/2024 1:08:08 PM |
$NRBO we got news | SmellMyFinger | investorshub | 01/20/2024 12:44:11 PM |
$NRBO short data if anyone is interested | SmellMyFinger | investorshub | 01/20/2024 7:35:42 AM |
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Inc. Website:
NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Asce...
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon ...
NeuroBo Pharmaceuticals Announces up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon the exercise in...